Nadav Kidron, President and CEO at ORAMED PHARMACEUTICALS INC. (ORMP), sold 220,000 shares at $20.11 ($4.4M) on 2021-08-09, disclosed to the SEC on 2021-08-11.
Open-market sale of $4.4M ORMP by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ORMP | BUY | 2018-07-12 | $722 | — | Filing → |
| ORMP | SELL | 2018-07-12 | $365 | — | Filing → |
| ORMP | BUY | 2016-05-12 | $7K | — | Filing → |